More tools:Markets·Screener·Research·Chat

GeneDx Holdings Corp. Class A Common Stock (WGS) Financial Statements

GeneDx Holdings Corp. Class A Common Stock
SIC 8000 · SERVICES-HEALTH SERVICES
FIGI BBG00XDHY5R7
XNAS · usd
86.48▲ 0.61 (0.71%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close85.87
Day's Range84.00 – 88.84
52-Week Range32.21 – 170.87
Volume492.8K
Avg Volume673.2K
Share Statistics
Shares Outstanding
Employees1,300
ExchangeXNAS
Listed2021-07-23
Share count as of July 27, 2026
Loading Income Statement…
Key questions about GeneDx Holdings Corp. Class A Common Stock (WGS)
What is GeneDx Holdings Corp. Class A Common Stock's Market Cap?
GeneDx Holdings Corp. Class A Common Stock's Market Cap is $2.6B, based on as-reported figures from SEC (XBRL) filings.
What is GeneDx Holdings Corp. Class A Common Stock's Enterprise Value?
GeneDx Holdings Corp. Class A Common Stock's Enterprise Value is $2.5B, based on as-reported figures from SEC (XBRL) filings.
What is GeneDx Holdings Corp. Class A Common Stock's Price / Sales?
GeneDx Holdings Corp. Class A Common Stock's Price / Sales is 5.7×, based on as-reported figures from SEC (XBRL) filings.
What is GeneDx Holdings Corp. Class A Common Stock's EV / Revenue?
GeneDx Holdings Corp. Class A Common Stock's EV / Revenue is 5.6×, based on as-reported figures from SEC (XBRL) filings.
What is GeneDx Holdings Corp. Class A Common Stock's EV / EBITDA?
GeneDx Holdings Corp. Class A Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is GeneDx Holdings Corp. Class A Common Stock's Revenue (TTM)?
GeneDx Holdings Corp. Class A Common Stock's Revenue (TTM) is $454.4M, based on as-reported figures from SEC (XBRL) filings.
What is GeneDx Holdings Corp. Class A Common Stock's Net Income (TTM)?
GeneDx Holdings Corp. Class A Common Stock's Net Income (TTM) is -$106.4M, based on as-reported figures from SEC (XBRL) filings.
What is GeneDx Holdings Corp. Class A Common Stock's EBITDA?
GeneDx Holdings Corp. Class A Common Stock's EBITDA is -$81.5M, based on as-reported figures from SEC (XBRL) filings.
What is GeneDx Holdings Corp. Class A Common Stock's Diluted EPS (TTM)?
GeneDx Holdings Corp. Class A Common Stock's Diluted EPS (TTM) is -3.57, based on as-reported figures from SEC (XBRL) filings.
What is GeneDx Holdings Corp. Class A Common Stock's EBITDA Margin?
GeneDx Holdings Corp. Class A Common Stock's EBITDA Margin is -17.9%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Total revenue
YoY growth+11.4%+17.4%+26.5%+51.9%
Cost of services
Gross profit
% of revenue68.4%66.7%69.6%72.4%
Research and development
Selling, general and administrative——
Impairment loss——
(Loss) income from operations
% of revenue-15.3%-56.2%-11.8%-2.8%
Non-operating (expense) income, net
Change in fair value of financial liabilities
Interest expense, net
Loss on extinguishment of debt——
Other income (expense), net
Total non-operating (expense) income, net
(Loss) income before income taxes
Income tax benefit (expense)
Net (loss) income
% of revenue-15.5%-61.9%-14.6%-6.5%
Other comprehensive (loss) income, net of tax
Unrealized loss related to available for sale securities, net
Comprehensive (loss) income
Basic (loss) earnings per share, Class A common stock (in dollars per share)
Diluted (loss) earnings per share, Class A common stock (in dollars per share)